Skip to main content

Table 2 Bone marrow findings subdivided after response to primary therapy

From: Presence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer

Bone marrow findings Poor responder (n = 45) Responder (n = 111)
  Progressive disease (n = 5) Stable disease (n = 40) Stable disease + progressive disease (n = 45) Partial remission (n = 87) Complete remission (n = 24) Partial remission + complete remission (n = 111)
Disseminated tumor cell negative (n = 56) 1 (20%) 11 (28%) 12 (26%) 34 (39%) 10 (42%) 44 (40%)
Only apoptotic cells (n = 17) 0 (0%) 2 (5%) 2 (4%) 11 (13%) 4 (17%) 15 (14%)
Nonapoptotic cells + apoptotic cells (n = 19) 0 (0%) 7 (18%) 7 (16%) 10 (12%) 2 (8%) 12 (11%)
Nonapoptotic cells (n = 64) 4 (80%) 20 (50%) 24 (52%) 32 (37%) 8 (33%) 40 (36%)
\